Adverse Events During Physiotherapy at Intensive Care Unit In Patients Undergoing Cardiac Surgery

NCT ID: NCT03552887

Last Updated: 2018-06-25

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Total Enrollment

323 participants

Study Classification

OBSERVATIONAL

Study Start Date

2016-06-01

Study Completion Date

2017-11-30

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

This study aims to estimate the incidence of adverse events during physiotherapy at intensive care unit (ICU) in adult patients undergoing cardiac surgery and to identify predictors of those events. This is a prospective cohort study, and the investigators observed all types of physiotherapy interventions in patients admitted at surgical ICU.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Physiotherapy intervention practice in patients after cardiac surgery has been associated with better clinical outcomes, but the safety of such interventions are not fully understood.

A prospective observational study of patients admitted at surgical ICU, aged \> 18 years old, undergoing cardiac surgery was conducted to estimate the incidence of adverse events during physiotherapy interventions in those patients and to identify predictors of adverse events.

Physiotherapy interventions were observed, performed by physiotherapists outside of the protocol. The occurrence of adverse events or physiological abnormality were recorded, classifying them according to the symptomatic consequences for the patient, from grade 1 ("near miss", additional intervention not required) to grade 5 (death). The investigators collected clinical characteristics of patients, such as sequential organ failure assessment (SOFA) score, comorbidities, sedation leve and pain. Participants were followed up to hospital discharge.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Adverse Event Physiotherapy Intensive Care Units Cardiac Surgery Postoperative

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Observational Model Type

COHORT

Study Time Perspective

PROSPECTIVE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Postoperative patients

Cohort of patients undergoing cardiac surgery, aged ≥ 18 years old, who had received any physiotherapy intervention

Cardiac Surgery

Intervention Type PROCEDURE

Any type of cardiac surgery

Physiotherapy

Intervention Type PROCEDURE

Any type of physiotherapy intervention, performed by physiotherapists outside of the protocol

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Cardiac Surgery

Any type of cardiac surgery

Intervention Type PROCEDURE

Physiotherapy

Any type of physiotherapy intervention, performed by physiotherapists outside of the protocol

Intervention Type PROCEDURE

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Patients undergoing cardiac surgery
* Age ≥ 18 years old
* Patients who are receiving any physiotherapy intervention

Exclusion Criteria

* Neurological and cognitive impairment
Minimum Eligible Age

18 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

University of Sao Paulo General Hospital

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Emilia Nozawa, PT PhD

Vice Director, Physiotherapy Department

Responsibility Role PRINCIPAL_INVESTIGATOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Emilia Nozawa, PhD, PT

Role: PRINCIPAL_INVESTIGATOR

Instituto do Coracao, Hospital das Clinicas, USP

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

51256215.5.0000.0068

Identifier Type: OTHER

Identifier Source: secondary_id

1391854

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.

In-line Filters on ICU
NCT02281604 COMPLETED